News Room

Plexus Ventures advises Cinfa Group in PLG’s “Deal of the Year”

March 26, 2019

London, England – The Pharmaceutical Licensing Group, whose mission is promote and support excellence in deal making across the healthcare industry, recently awarded Mundipharma International its inaugural “PLG Deal of the Year” for its acquisition of Cinfa Biotech.

This deal helped both companies to achieve critical strategic goals – for Mundipharma, additional medicines and a network to develop future biosimilars; and for Cinfa Group, the ability to invest greater resources in support of small molecule and specialty generic products and the OTC/consumer healthcare product lines.

Plexus Ventures served as advisors to Cinfa Group on this transaction.


About Plexus Ventures

Now in its 29th year, Plexus Ventures provides strategic advice, business development and alliance management services to clients in the pharmaceutical, consumer healthcare and drug delivery industries worldwide. Plexus Ventures assists its clients in the areas of in-licensing, out-licensing, acquisitions, divestitures and strategic partnerships. With offices in Barcelona, Basel, Beijing, Indianapolis, London, Los Angeles, Milan, Oxford, Philadelphia and Tokyo, Plexus Ventures possesses the capabilities to effectively serve clients in North America, South America, Europe and Asia. Plexus Ventures is both well-known and well respected by leading pharmaceutical and consumer healthcare companies worldwide.